Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Internal Medicine

• Publication date

  2011-07-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-155-2-201107190-00002PMID 21768580PMCID PMC3793257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.

  2011cited by this paper
• Microsatellite instability in colorectal cancer

  2011cited by this paper
• Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?

  2010cited by this paper
• Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.

  2010cited by this paper
• Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

  2010cited by this paper
• To screen or not to screen for Lynch syndrome.

  2010cited by this paper
• Microsatellite instability in colorectal cancer.

  2010cited by this paper
• [Colorectal cancer screening].

  2010cited by this paper
• The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

  2010cited by this paper
• Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.

  2010cited by this paper
• Therapeutic Targeting of the DNA Mismatch Repair Pathway

  2010cited by this paper
• Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population

  2010cited by this paper
• One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

  2010cited by this paper
• Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

  2009cited by this paper
• EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

  2009cited by this paper
• Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.

  2009cited by this paper
• Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy

  2009cited by this paper
• Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario

  2009cited by this paper
• Risk of perforation from a colonoscopy in adults: a large population-based study.

  2009cited by this paper
• Cost-effectiveness analysis of annual screening strategies for endometrial cancer.

  2009cited by this paper
• Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation

  2009cited by this paper
• Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer

  2009cited by this paper
• Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting

  2009cited by this paper
• Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome

  2009cited by this paper
• Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice.

  2008cited by this paper
• Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.

  2008cited by this paper
• Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force

  2008cited by this paper
• Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry.

  2008cited by this paper
• Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting

  2008cited by this paper
• Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients

  2008cited by this paper
• Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

  2008cited by this paper
• Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?

  2008cited by this paper
• Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.

  2008cited by this paper
• Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

  2008cited by this paper
• Process and outcome in communication of genetic information within families: a systematic review

  2007cited by this paper
• Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing

  2007cited by this paper
• The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing

  2007cited by this paper
• Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome

  2007cited by this paper
• Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

  2007cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families

  2006cited by this paper
• Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

  2006cited by this paper
• Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications

  2006cited by this paper
• The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC)

  2006cited by this paper
• New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing.

  2006cited by this paper
• Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians

  2006cited by this paper
• Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.

  2006cited by this paper
• Structure and function of the components of the human DNA mismatch repair system

  2006cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials

  2006cited by this paper
• Microsatellite instability in colorectal cancer

  2006cited by this paper
• Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

  2005cited by this paper
• It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population.

  2005cited by this paper
• Short term benefits for laparoscopic colorectal resection.

  2005cited by this paper
• Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

  2005cited by this paper
• Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

  2005cited by this paper
• Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

  2005cited by this paper
• Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

  2005cited by this paper
• Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

  2005cited by this paper
• The "duty to warn" a patient's family members about hereditary disease risks.

  2004cited by this paper
• Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial.

  2004cited by this paper
• Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma

  2004cited by this paper
• Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study

  2004cited by this paper
• Cost effectiveness of a new strategy to identify HNPCC patients

  2004cited by this paper
• Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

  2004cited by this paper
• How families communicate about HNPCC genetic testing: Findings from a qualitative study

  2003cited by this paper
• An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer

  2003cited by this paper
• Duty to warn at‐risk relatives for genetic disease: Genetic counselors' clinical experience

  2003cited by this paper
• Medical geneticists' duty to warn at‐risk relatives for genetic disease

  2003cited by this paper
• Hereditary colorectal cancer.

  2003cited by this paper
• Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study.

  2003cited by this paper
• Cost-Effectiveness Analyses of Colorectal Cancer Screening

  2002cited by this paper
• Laparoscopic Versus Open Colorectal Surgery: A Randomized Trial on Short-Term Outcome

  2002cited by this paper
• Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force.

  2002cited by this paper
• Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma

  2002cited by this paper
• A population based cohort study of patients with multiple colon and endometrial cancer: Correlation of microsatellite instability (msi) status, age at diagnosis and cancer risk

  2001cited by this paper
• Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.

  2001cited by this paper
• The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

  2001cited by this paper
• Cost-Effectiveness of Microsatellite Instability Screening as a Method for Detecting Hereditary Nonpolyposis Colorectal Cancer

  2001cited by this paper
• Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

  2000cited by this paper
• Population-based molecular detection of hereditary nonpolyposis colorectal cancer.

  2000cited by this paper
• Endoscopic perforation of the colon: lessons from a 10-year study

  2000cited by this paper
• Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

  2000cited by this paper
• Cancer risk in mutation carriers of DNA‐mismatch‐repair genes

  1999cited by this paper
• New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

  1999cited by this paper
• A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report.

  1998cited by this paper
• Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Cancer risk associated with germline DNA mismatch repair gene mutations.

  1997cited by this paper
• Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

  1996cited by this paper
• Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

  1996cited by this paper
• Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families.

  1995cited by this paper
• Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

  1993cited by this paper
• The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

  1993cited by this paper
• A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

  1992cited by this paper
• Summary of Recommendations: The Evaluation of Genomic Applications

  year unknowncited by this paper

• In Our Scope of Practice: Genetic Risk Assessment and Testing for GI Cancers and Polyposis in Gastroenterology.

  2025cites this paper
• PLSKB: An Interactive Knowledge Base to Support Diagnosis, Treatment, and Screening of Lynch Syndrome on the Basis of Precision Oncology

  2025cites this paper
• Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening.

  2025cites this paper
• Choice architecture in cascade genetic testing (CHARGE study) for hereditary cancer: Design of a hybrid type I randomized feasibility trial.

  2025cites this paper
• Cost-Utility Analysis of Universal Lynch Syndrome Screening among Colorectal Cancer Patients in a Low-Middle-Income Country

  2025cites this paper
• Hereditary Gastrointestinal Cancer Syndromes and Early‐Onset Gastrointestinal Cancers

  2025cites this paper
• Cost-Effectiveness of Lynch Syndrome Identification Strategies in Individuals with Colorectal Cancer and the Impact on At-Risk Relatives.

  2025cites this paper
• Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study

  2025cites this paper
• Humangenetische Diagnostik bei onkologischen Erkrankungen

  2025cites this paper
• Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2024 for the clinical practice of hereditary colorectal cancer

  2025cites this paper
• The Clinical Outcomes Among Patients Under 60 Years Old with Lynch Syndrome: Variations Based on Different Mutation Patterns

  2025cites this paper
• Therapeutic targeting of mismatch repair-deficient cancers

  2025cites this paper
• Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.

  2024cites this paper
• How hereditary cancer risk disclosure to relatives is handled in practice - Patient perspectives from a Swedish cancer genetics clinic.

  2024cites this paper
• Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice

  2024cites this paper
• Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approach

  2024cites this paper
• Microsatellite instability evaluation by a novel PCR‐based 8‐loci test kit in colorectal cancer

  2024cites this paper
• A Randomized Trial of Two Remote Healthcare Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

  2024cites this paper
• Who has the responsibility to inform relatives at risk of hereditary cancer? A population-based survey in Sweden

  2024cites this paper
• Lynch Syndrome Screening and Surveillance Trends among Gastroenterologists in Japan: A Questionnaire Survey-based Analysis

  2024cites this paper
• Humangenetische Diagnostik bei onkologischen Erkrankungen

  2024cites this paper
• Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing

  2024cites this paper
• Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation.

  2024cites this paper
• The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programme

  2023cites this paper
• MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome

  2023cites this paper
• Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis

  2023cites this paper
• Province-Wide Ascertainment of Lynch Syndrome in Manitoba.

  2023cites this paper
• A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies

  2023cites this paper
• Germline Genetic Testing After Cancer Diagnosis.

  2023cites this paper
• Incidental screening of descending colon carcinoma by 18F-FDG PET/MR imaging in a patient with endometrial carcinoma: A case report of Lynch syndrome

  2023cites this paper
• Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis

  2022cites this paper
• Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis

  2022cites this paper
• Evaluating the quality of the economic evidence in colorectal cancer genomics studies.

  2022cites this paper
• Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment

  2022cites this paper
• Surgical Aspect of Microsatellite instability in Colorectal Cancer

  2022cites this paper
• Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer—A Prospective Analysis

  2022cites this paper
• Evaluation of microsatellite instability in routine examinations of surgical samples

  2022cites this paper
• Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review

  2022cites this paper
• Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis.

  2022cites this paper
• What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer?

  2022cites this paper
• Economics and Precision Medicine.

  2022cites this paper
• Screening for Lynch Syndrome: Optimal Strategies and Performance Remain a Moving Target.

  2022cites this paper
• Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention

  2022cites this paper
• DNA Mismatch Repair Proteins and BRAF V600E Detection by Immunohistochemistry in Colorectal Cancer Demonstrates Concordance with Next Generation Sequencing

  2022cites this paper
• A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

  2022cites this paper
• Cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model

  2022cites this paper
• Somatic tumor testing implications for Lynch syndrome germline genetic testing.

  2022cites this paper
• A Canadian Provincial Screening Program for Lynch Syndrome

  2022cites this paper
• Oncology Informatics for Lynch Syndrome Research and Care: A Literature Review.

  2022cites this paper
• Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for all GI Cancers?

  2022cites this paper
• Cost-Effectiveness of Colorectal Cancer Genetic Testing

  2021cites this paper
• Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma

  2021cites this paper
• Retroactive assessment for DNA mismatch repair deficiency in women with a history of endometrial cancer

  2021cites this paper
• Block, Blood or Both? Outcomes, Opportunities, and Barriers in Colorectal Cancer Universal Testing.

  2021cites this paper
• AGA Institute and CAP Quality Measure Development for Detection of MMR Deficiency and Lynch Syndrome Management.

  2021cites this paper
• Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort

  2021cites this paper
• How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies

  2021cites this paper
• MSIFinder: a python package for detecting MSI status using random forest classifier

  2021cites this paper
• Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention.

  2021cites this paper
• What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk?

  2021cites this paper
• Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation

  2021cites this paper
• Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.

  2021cites this paper
• Accounting for Intergenerational Cascade Testing in Economic Evaluations of Clinical Genomics: A Scoping Review.

  2021cites this paper
• Measuring and Improving Quality of Colonoscopy for Colorectal Cancer Screening.

  2021cites this paper
• Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.

  2021cites this paper
• Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer

  2021cites this paper
• A Focus Group Study of Perceptions of Genetic Risk Disclosure in Members of the Public in Sweden: “I’ll Phone the Five Closest Ones, but What Happens to the Other Ten?”

  2021cites this paper
• Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases.

  2020cites this paper
• Current Microsatellite Instability Testing in Management of Colorectal Cancer.

  2020cites this paper
• Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative

  2020cites this paper
• Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden

  2020cites this paper
• Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas

  2020cites this paper
• Germline mutational profile of Chinese patients under 70 years old with colorectal cancer

  2020cites this paper
• Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease

  2020cites this paper
• Economic evaluations of big data analytics for clinical decision-making: a scoping review

  2020cites this paper
• Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consent.

  2020cites this paper
• Age‐dependent performance of BRAF mutation testing in Lynch syndrome diagnostics

  2020cites this paper
• The clinical utility of microsatellite instability in colorectal cancer.

  2020cites this paper
• Präkanzerosen und Malignome des Gastrointestinaltrakts

  2020cites this paper
• Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.

  2020cites this paper
• Distinct clinical phenotype and genetic testing strategy for Lynch syndrome in China based on a large colorectal cancer cohort

  2020cites this paper
• Tumors of the Gastrointestinal System Including the Pancreas

  2020cites this paper
• Implementation of Universal Tumor Screening of Colorectal Cancer for Detection of Lynch Syndrome at a Hispanic-Rich County Hospital.

  2020cites this paper
• Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer

  2020cites this paper
• Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA

  2020cites this paper
• Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy

  2020cites this paper
• Patients in Whom to Consider Genetic Evaluation and Testing for Hereditary Colorectal Cancer Syndromes.

  2019cites this paper
• Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center

  2019cites this paper
• Effective Identification of Lynch Syndrome in Gastroenterology Practice

  2019cites this paper
• Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort

  2019cites this paper
• Cancer Screening and Prevention Highlights in Gynecologic Cancer.

  2019cites this paper
• Current Approaches to Germline Cancer Genetic Testing.

  2019cites this paper
• Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry

  2019cites this paper
• Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer.

  2019cites this paper
• Hereditary Cancer Syndromes-A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes.

  2019cites this paper
• Endometrial cancer: modern concepts of screening

  2019cites this paper
• Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators

  2019cites this paper
• Clinical and Cost Effectiveness of Two “New” Lynch Syndrome Case Finding Protocols in Endometrial Cancer Population Contrasted with the IHC-based Protocol

  2019cites this paper
• A dedicated high‐quality service for the management of patients with an inherited risk of colorectal cancer

  2019cites this paper
• The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine

  2019cites this paper